127 related articles for article (PubMed ID: 25771811)
1. VPS35 and EIF4G1 interactions and novel candidate genes for PD: from genes to pathways and back.
Erro R
Mov Disord; 2015 Apr; 30(4):499. PubMed ID: 25771811
[No Abstract] [Full Text] [Related]
2. Linking the VPS35 and EIF4G1 pathways in Parkinson's disease.
Ross OA; Cook C; Petrucelli L
Neuron; 2015 Jan; 85(1):1-3. PubMed ID: 25569341
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on α-synuclein.
Dhungel N; Eleuteri S; Li LB; Kramer NJ; Chartron JW; Spencer B; Kosberg K; Fields JA; Stafa K; Adame A; Lashuel H; Frydman J; Shen K; Masliah E; Gitler AD
Neuron; 2015 Jan; 85(1):76-87. PubMed ID: 25533483
[TBL] [Abstract][Full Text] [Related]
4. D620N mutation in the VPS35 gene and R1205H mutation in the EIF4G1 gene are uncommon in the Greek population.
Kalinderi K; Bostantjopoulou S; Katsarou Z; Dimikiotou M; Fidani L
Neurosci Lett; 2015 Oct; 606():113-6. PubMed ID: 26300542
[TBL] [Abstract][Full Text] [Related]
5. Frequency of the ASP620ASN mutation in VPS35 and Arg1205His mutation in EIF4G1 in familial Parkinson's disease from South Italy.
Gagliardi M; Annesi G; Tarantino P; Nicoletti G; Quattrone A
Neurobiol Aging; 2014 Oct; 35(10):2422.e1-2. PubMed ID: 24854799
[TBL] [Abstract][Full Text] [Related]
6. VPS35 Asp620Asn and EIF4G1 Arg1205His mutations are rare in Parkinson disease from southwest China.
Chen Y; Chen K; Song W; Chen X; Cao B; Huang R; Zhao B; Guo X; Burgunder J; Li J; Shang HF
Neurobiol Aging; 2013 Jun; 34(6):1709.e7-8. PubMed ID: 23261770
[TBL] [Abstract][Full Text] [Related]
7. VPS35 and EIF4G1 mutations are rare in Parkinson's disease among Indians.
Sudhaman S; Behari M; Govindappa ST; Muthane UB; Juyal RC; Thelma BK
Neurobiol Aging; 2013 Oct; 34(10):2442.e1-3. PubMed ID: 23726718
[TBL] [Abstract][Full Text] [Related]
8. Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease.
Nuytemans K; Bademci G; Inchausti V; Dressen A; Kinnamon DD; Mehta A; Wang L; Züchner S; Beecham GW; Martin ER; Scott WK; Vance JM
Neurology; 2013 Mar; 80(11):982-9. PubMed ID: 23408866
[TBL] [Abstract][Full Text] [Related]
9. Increased copper toxicity in Saccharomyces cerevisiae lacking VPS35, a component of the retromer and monogenic Parkinson disease gene in humans.
Sowada N; Stiller B; Kubisch C
Biochem Biophys Res Commun; 2016 Aug; 476(4):528-533. PubMed ID: 27262440
[TBL] [Abstract][Full Text] [Related]
10. Update on genetics of parkinsonism.
Fujioka S; Wszolek ZK
Neurodegener Dis; 2012; 10(1-4):257-60. PubMed ID: 22261420
[TBL] [Abstract][Full Text] [Related]
11. EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson's disease from South Africa.
Blanckenberg J; Ntsapi C; Carr JA; Bardien S
Neurobiol Aging; 2014 Feb; 35(2):445.e1-3. PubMed ID: 24080171
[TBL] [Abstract][Full Text] [Related]
12. The importance of rare DNA variation in neurologic disease: cautionary tale.
Haines JL
Neurology; 2013 Mar; 80(11):974-5. PubMed ID: 23408868
[TBL] [Abstract][Full Text] [Related]
13. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM
Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137
[TBL] [Abstract][Full Text] [Related]
14. The EIF4G1 gene and Parkinson's disease.
Deng H; Wu Y; Jankovic J
Acta Neurol Scand; 2015 Aug; 132(2):73-8. PubMed ID: 25765080
[TBL] [Abstract][Full Text] [Related]
15. Genetics of Parkinson disease and other movement disorders.
Kumar KR; Lohmann K; Klein C
Curr Opin Neurol; 2012 Aug; 25(4):466-74. PubMed ID: 22772876
[TBL] [Abstract][Full Text] [Related]
16. EIF4G1 mutations do not cause Parkinson's disease.
Nichols N; Bras JM; Hernandez DG; Jansen IE; Lesage S; Lubbe S; Singleton AB;
Neurobiol Aging; 2015 Aug; 36(8):2444.e1-4. PubMed ID: 26022768
[TBL] [Abstract][Full Text] [Related]
17. EIF4G1 is neither a strong nor a common risk factor for Parkinson's disease: evidence from large European cohorts.
Huttenlocher J; Krüger R; Capetian P; Lohmann K; Brockmann K; Csoti I; Klein C; Berg D; Gasser T; Bonin M; Riess O; Bauer P
J Med Genet; 2015 Jan; 52(1):37-41. PubMed ID: 25368108
[TBL] [Abstract][Full Text] [Related]
18. VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease.
Miura E; Hasegawa T; Konno M; Suzuki M; Sugeno N; Fujikake N; Geisler S; Tabuchi M; Oshima R; Kikuchi A; Baba T; Wada K; Nagai Y; Takeda A; Aoki M
Neurobiol Dis; 2014 Nov; 71():1-13. PubMed ID: 25107340
[TBL] [Abstract][Full Text] [Related]
19. High expression levels of the D686N Parkinson's disease mutation in VPS35 induces α-synuclein-dependent toxicity in yeast.
Huang Y; Chen X; He X; Guo C; Sun X; Liang F; Long S; Lu X; Feng L; Guo W; Zeng Y; Pei Z
Mol Med Rep; 2017 Jul; 16(1):254-262. PubMed ID: 28487947
[TBL] [Abstract][Full Text] [Related]
20. EIF4G1 Ala502Val and Arg1205His variants in Chinese patients with Parkinson disease.
Yuan L; Song Z; Xu H; Gu S; Zhu A; Gong L; Zhao Y; Deng H
Neurosci Lett; 2013 May; 543():69-71. PubMed ID: 23562511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
